These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 21536825

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
    Pardi DS, Loftus EV, Kremers WK, Keach J, Lindor KD.
    Gastroenterology; 2003 Apr; 124(4):889-93. PubMed ID: 12671884
    [Abstract] [Full Text] [Related]

  • 3. Ursodiol for all?
    Lee SD, Surawicz CM.
    Am J Gastroenterol; 2001 Dec; 96(12):3437-8. PubMed ID: 11774966
    [No Abstract] [Full Text] [Related]

  • 4. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
    Wolf JM, Rybicki LA, Lashner BA.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):783-8. PubMed ID: 16225486
    [Abstract] [Full Text] [Related]

  • 5. [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
    MMW Fortschr Med; 2006 Jun 15; 148(24):42-3. PubMed ID: 16850808
    [No Abstract] [Full Text] [Related]

  • 6. Colitis-associated sclerosing cholangitis in children: a single centre experience.
    Noble-Jamieson G, Heuschkel RB, Torrente F, Hadzic N, Zilbauer M.
    J Crohns Colitis; 2013 Nov 15; 7(10):e414-8. PubMed ID: 23485432
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A.
    Ital J Gastroenterol; 1996 Apr 15; 28(3):178-80. PubMed ID: 8789831
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemoprevention in ulcerative colitis: narrowing the gap between clinical practice and research.
    Hawk ET, Viner JL.
    Ann Intern Med; 2001 Jan 16; 134(2):158-60. PubMed ID: 11177320
    [No Abstract] [Full Text] [Related]

  • 14. Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
    Zimmer V, Lammert F.
    EBioMedicine; 2017 Feb 16; 15():10-11. PubMed ID: 28007481
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent.
    Mueller T, Bianchi L, Menges M.
    Eur J Gastroenterol Hepatol; 2008 Mar 16; 20(3):232-6. PubMed ID: 18301306
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of cholestatic liver diseases].
    Karvonen AL.
    Duodecim; 2003 Mar 16; 119(6):533-9. PubMed ID: 12708340
    [No Abstract] [Full Text] [Related]

  • 18. [Primary sclerosing cholangitis. A report of 4 cases].
    Rodríguez H, Dehesa M, Aguirre García J, Blasco JM.
    Rev Gastroenterol Mex; 1991 Mar 16; 56(2):71-5. PubMed ID: 1947618
    [Abstract] [Full Text] [Related]

  • 19. Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
    Charatcharoenwitthaya P, Lindor KD.
    Clin Gastroenterol Hepatol; 2007 Jan 16; 5(1):32-6. PubMed ID: 17234554
    [No Abstract] [Full Text] [Related]

  • 20. Rapid progress of acute suppurative cholangitis to secondary sclerosing cholangitis sequentially followed-up by endoscopic retrograde cholangiography.
    Tanaka Y, Koshiyama H, Nakao K, Makita Y, Kobayashi Y, Yoshida Y, Kimura M, Adachi Y.
    Endoscopy; 2001 Jul 16; 33(7):633-5. PubMed ID: 11473338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.